
Science Resources RSS Feeds
|
 |
 |
 |
Infectious diseases experts issue blueprint to avert
June 18, 2007
Call for federal investments to immunize adults, adolescents New vaccines are available to make significant gains against cervical cancer deaths and debilitating pain from shingles, but infectious diseases experts warn that their full potential will not be realized without changes in the way vaccines for adults and adolescents are promoted, financed, and delivered in the United States.
The Infectious Diseases Society of America (IDSA) has released a new "blueprint for action" to prevent tens of thousands of deaths and illnesses caused by these and other diseases that can be avoided with a few simple shots. The blueprint is published in the June 15 issue of Clinical Infectious Diseases.
"We have done a great job in this country delivering vaccines to children, but we have done an awful job delivering vaccines to adults," said Neal A. Halsey, MD, professor at the Johns Hopkins University Bloomberg School of Public Health and chair of the IDSA Immunization Work Group that developed the policy blueprint.
For example, he points out that more than 90 percent of U.S. children are immunized against measles, mumps, whooping cough, hepatitis B, and other diseases. Rates of these diseases are at or near historic lows. In contrast, an estimated 175,000 adults are hospitalized and 6,000 die each year from pneumococcal pneumonia, but one in three adults over 65 has not been vaccinated against it. The Centers for Disease Control and Prevention (CDC) estimates that the cost of treating diseases that vaccines could prevent exceeds $10 billion annually.
Cost is one factor in why adults do not get vaccinated-particularly the uninsured. "CDC has very effective systems for delivering vaccines to underserved children," said IDSA work group member Walter A. Orenstein, MD, associate director of the Emory Vaccine Center and former head of CDC's immunization program. "One of them is Section 317 of the Public Health Service Act, which helps state and local health departments provide vaccines to uninsured or underinsured patients-largely children-for free. Section 317 must now be expanded to catch underserved adults at highest risk."
While the program is cost-effective, expanding Section 317 will require a significant infusion of cash. Section 317's current $520 million budget will need an additional $170 million per year in order to cover all vaccines for uninsured adults, according to a recent CDC estimate. "It is essential that we provide adults access to these vaccines that save lives and prevent illnesses," Dr. Orenstein said, "but immunizing adults must not be done at the expense of children."
IDSA also is calling for all plans to cover all adult and adolescent vaccines recommended by CDC's Advisory Committee on Immunization Practices and to pay physicians adequately for office costs associated with immunization. Further, managed care plans should be measured in part on how well they immunize patients. Another principle supports exploring where immunization can appropriately take place outside the traditional office setting. Funding to support research into vaccines and vaccine delivery must be increased, and resources must be available to gather data on safety, efficacy, and usage.
Physicians and patients also must be part of the solution, according to the IDSA blueprint. "Part of the problem lies with physicians, who are not accustomed to offering vaccines during routine visits with adult patients; and with patients, who are unaware the vaccines exist," said IDSA work group member William Schaffner, MD, chair of the Department of Preventive Health at Vanderbilt University. Doctors who serve adults must begin assessing adult immunization needs during routine preventive health care visits. Also, CDC should launch an education campaign to help improve awareness about vaccines and the illnesses they can prevent in adults.
"As health care workers, we set an example for our patients," Dr. Schaffner added. "We all must be fully immunized."
"We have the tools to make dramatic improvements in adult and adolescent health, as we have for children," said Andrew T. Pavia, MD, chair of IDSA's National and Global Public Health Committee, Chief of Pediatric Infectious Diseases at the University of Utah, and a member of the National Vaccine Advisory Committee. "IDSA's blueprint outlines the steps we must take to use these tools effectively. Now all we need is the will to take those steps."
Infectious Diseases Society of America
|
 |
Related Infectious Diseases Current Events and Infectious Diseases News Articles Infectious Diseases Current Events and Infectious Diseases News RSS Barn Personnel Experience Higher-Than Average Rates of Respiratory Symptoms The estimated 4.6 million Americans involved in the equine industry may be at risk of developing respiratory symptoms due to poor air quality in horse barns.
Preventing H1N1 spread to health care workers: Dilemma, debate and confusion A commentary in the December issue of The Lancet Infectious Diseases brings to light the gaps in knowledge on the transmission of a common pathogen - the influenza virus - and its impact on decisions about how best to protect health care workers.
New findings suggest strategy to help generate HIV-neutralizing antibodies New discoveries about anti-HIV antibodies may bring researchers a step closer to creating an effective HIV vaccine, according to a new paper co-authored by scientists at the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
The Protein Srebp2 Drives Cholesterol Formation in Prion-Infected Neuronal Cells Which May Promote Prion-Dependent Diseases The regulating protein Srebp2 drives cholesterol formation, which prions need for their propagation, in prion-infected neuronal cells.
Texas A&M Researchers Examine How Viruses Destroy Bacteria Viruses are well known for attacking humans and animals, but some viruses instead attack bacteria. Texas A&M University researchers are exploring how hungry viruses, armed with transformer-like weapons, attack bacteria, which may aid in the treatment of bacterial infections.
Pivotal study for PSD502 -- the first potential treatment for premature ejaculation At the annual meeting of the Sexual Medicine Society of North America (SMSNA), Inc. in San Diego, Sciele Pharma, Inc., a Shionogi Company and Plethora Solutions Limited, a wholly owned subsidiary of Plethora Solutions Holdings PLC ("Plethora" - AIM:PLE)., today presented data from its second positive pivotal study of PSD502 for the treatment of premature ejaculation (PE).
Research calls for better assessment of tests for tuberculosis, HIV/AIDS and malaria A rapid and accurate diagnosis is the first step towards treatment in the fight against infectious disease.
Small nanoparticles bring big improvement to medical imaging If you're watching the complex processes in a living cell, it is easy to miss something important-especially if you are watching changes that take a long time to unfold and require high-spatial-resolution imaging.
New explanation for nature's hardiest life form Got food poisoning? The cause might be bacterial spores, en extremely hardy survival form of bacteria, a nightmare for health care and the food industry and an enigma for scientists.
Aileron collaborates study in Nature: Stapled peptides inhibit Notch1 transcription factor This research validates the potential for Stapled Peptides to modulate key intracellular biological targets, such as transcription factors, that have not been addressable with current small molecule or biologic drug modalities. More Infectious Diseases Current Events and Infectious Diseases News Articles
|
 |

|
Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases: Expert Consult Premium Edition - Enhanced Online Features and Print
by Gerald L. Mandell (Author)
After thirty years, PPID is still the reference of choice for comprehensive, global guidance on diagnosing and treating the most challenging infectious diseases. Drs. Mandell, Bennett, and Dolin have substantially revised and meticulously updated, this new edition to save you time and to ensure you have the latest clinical and scientific knowledge at your fingertips. With new chapters, expanded and updated coverage, increased worldwide perspectives, and many new contributors, Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 7th Edition helps you identify and treat whatever infectious disease you see. And, as an Expert Consult title with enhanced online features, this updated 7th edition comes with convenient access to the full text online, regular...
|

|
Infectious Diseases: A Clinical Short Course, Second Edition (LANGE Clinical Medicine)
by Frederick Southwick (Author)
Gain a full understanding of clinical infectious diseases in just thirty days A Doody's Core Title! No other resource makes clinical infectious diseases more manageable and easy to master than Infectious Diseases: A Clinical Short Course. This one-of-a-kind self-instruction tool is organized by system/region as opposed to pathogens -- simulating how common pathogens and disorders would be encountered in rounds or in practice. For this reason, this remarkable resource is unsurpassed for learning how to associate pathogens with their corresponding impact on actual patients. Features: A true, concise “short course” format that can be read and understood in the span of a 30-day infectious disease rotation Numerous case examples...
|

|
Clinical Infectious Disease
by David Schlossberg (Editor)
This clinically-oriented, user-friendly text is the best on the market for infectious disease. Complete and comprehensive, Schlossberg's text will be an effective reference for any practitioner who may encounter these afflictions. The orientation of the volume is multi-faceted: in addition to the traditional organization of organ system and pathogen-related information, this text includes specific sections on the susceptible host, travel-related infections, nosocomial infections, infections related to trauma, and bioterrorism. The information on post-surgical infections will be of great interest to practicing surgeons. Informative algorithms, tables, and high-quality color photographs supplement many of the chapters in this conveniently-sized volume. For practicality and ease of use, one...
|

|
Infectious Diseases, Second Edition (EXPERT GUIDE SERIES- AMERICAN COLLEGE OF PHYSICIANS)
by James S. Tan (Editor), Michael J. Tan (Editor), Robert A. Salata (Editor), Thomas M. File Jr. (Editor)
Here s the expert guidance practitioners need to diagnose and treat the most commonly encountered infections! This fully revised and updated New Edition keeps readers current with the latest etiologic agents, the most appropriate diagnostic tests, and the most effective management options. The 2nd Edition features new chapters on Antimicrobial Agents for the Primary Care Physician and Prosthetic Joint Infections. FEATURES: -Examines infections of the central nervous system, heart and blood vessels, gastrointestinal tract, genitourinary system, respiratory tract, skeletal system, and the skin. -Features individual chapters on HIV, herpes virus, Lyme disease, and malaria. -Puts key information at the reader s fingertips with diagnostic and treatment tables throughout the text. -Reviews...
|

|
Infectious Disease: A Scientific American Reader (Scientific American Readers)
by Scientific American (Editor)
The international public health scare that resulted last year when a man infected with multidrug-resistant tuberculosis flew overseas from the United States and back illustrates both the fear and the potential impact of highly infectious diseases in a global age. At a time when scientists warn of the potential for an influenza epidemic to rival the deadly outbreak of 1919 and newspapers feature alarming headlines about incidences of mad cow disease, infectious disease will be a critical area of concern and scientific study in the twenty-first century. Infectious Disease collects thirty of the most exciting, innovative, and significant articles on communicable illness published in the pages of Scientific American magazine since 1993. With sections devoted to viral infections,...
|

|
Infectious Disease Epidemiology: Theory And Practice
by Kenrad E., M.D. Nelson (Author), Carolyn F. Masters, Ph.D. Williams (Author)
This thorough revision contains new chapters on principles of immunology, measles and polio, meningococcal infections, including pneumococcal, and influenza infections. The chapter on emerging infections has been divided into one of mosquito borne infections and includes West Nile Virus, Rift V and Dengue as well as other arthropod borne infections. SARS and Monkey Poxare included in the new chapter. All other chapters have been updated.
|

|
The A to Z of Infectious Diseases (Concise Encyclopedia)
by Carol Turkington (Author), Bonnie Lee, M.d. Ashby (Author)
In the past 25 years, more than 30 new germs affecting humans have emerged onto the medical scene, most of them rising from animals. New diseases like the avian flu, Ebola, SARS, and weaponized viruses such as anthrax and smallpox pose a growing danger to the world. With the threat of infectious diseases remaining constant, it is essential to have clear and concise information on this topic. "The A to Z of Infectious Diseases" provides more than 600 up-to-date entries covering the latest research, new treatments and vaccines, and rising diseases such as mad cow disease. Appendixes include drugs used to treat infectious diseases, tips for home disinfection, and lists of helpful organizations and publications, making this the ultimate resource for knowledge about infectious diseases. Topics...
|

|
Case Studies in Infectious Disease
by Peter Lydyard (Author), Michael Cole (Author), John Holton (Author), Will Irving (Author), Nino Porakishvili (Author), Pradhib Venkatesan (Author), Kate Ward (Author)
Case Studies in Infectious Disease presents forty case studies featuring the most important human infectious diseases worldwide. Written for students of microbiology and medicine this book describes the natural history of infection from point of entry of the pathogen through pathogenesis, followed by clinical presentation, diagnosis and treatment.
Five core sets of questions are posed in each case. What is the nature of the infectious agent, how does it gain access to the body, what cells are infected, and how does the organism spread? What are the host defense mechanisms against the agent and how is the disease caused? What are the typical manifestations of the infection and the complications that can occur? How is the infection diagnosed and what is the...
|

|
Current Diagnosis & Treatment In Infectious Diseases (Current Diagnosis and Treatment in Infectious Diseases)
by Walter R. Wilson (Author)
Numerous quick-access boxes and tables summarize key information on one of the leading causes of death. This title covers the essentials of diagnosis, syndromes in children and adults, and treatments, including first and second-choice options. It blends practice-oriented, authoritative coverage with just the right amount of microbiology for understanding diagnostic and management decisions.
|

|
Infectious Diseases (Infectious Diseases ( Gorbach ))
by Sherwood L Gorbach (Editor), John G Bartlett (Editor), Neil R Blacklow (Editor)
Tufts Univ. School of Medicine, Boston, MA. Provides comprehensive guidelines on the diagnosis, treatment, and prevention of every infectious disease seen in current clinical practice. Discusses new information on hospital infections, bioterrorism, toxic shock syndrome, West NIle virus, hepatitis, and more. Previous edition: c1998. DNLM: Communicable Diseases.
|
|